NDC 50242-917

Tecentriq 1200 mg per 20 mL injection, solution

On the label: Genentech, Inc..

Switzerland: 2United States: 1Germany: 1

Where it's made

FactoryWhereRoleLast FDA inspection
F. Hoffmann-La Roche AGKaiseraugst, SwitzerlandMakes it, makes the active ingredient, tests it, packages it and labels it Problems found, fixed voluntarilyMar 21, 2025 · 8 inspections
F. Hoffmann-La Roche AGBasel, SwitzerlandMakes the active ingredient and tests it Problems found, fixed voluntarilyMay 9, 2025 · 9 inspections
Genentech, Inc.Hillsboro, OR, United StatesMakes it, tests it, packages it and labels it Problems found, fixed voluntarilyApr 19, 2024 · 7 inspections
Roche Diagnostics GmbHPenzberg, GermanyMakes the active ingredient and tests it Problems found, fixed voluntarilyMay 22, 2025 · 6 inspections
Genentech, Inc.South San Francisco, CA, United StatesTests it No problems foundMay 15, 2026 · 37 inspections
Genentech, Inc.Oceanside, CA, United StatesTests it No problems foundAug 16, 2024 · 5 inspections
Roche Diagnostics GmbHMannheim, GermanyTests it Problems found, fixed voluntarilyOct 29, 2021 · 5 inspections

Product details

Generic drug
Atezolizumab: every company that makes it
Form
injection, solution, intravenous
Strength
1200 mg per 20 mL
Approval
BLA BLA761034
On the market since
May 18, 2016
Package NDCs
50242-917-01 50242-917-86
Official label
DailyMed (National Library of Medicine), updated Oct 13, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?